In a report released today, Matt Miksic from Barclays maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.2% year on year to $10.97 billion. Its non-GAAP profit ...

In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Abbott Laboratories (ABT – Research Report). The ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks discussed by ...

Using the 2 Stage Free Cash Flow to Equity, Abbott Laboratories fair value estimate is US$152 With US$129 share price, Abbott Laboratories appears to be trading close to its estimated fair value ...

The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson (NYSE: JNJ) higher in 2025. While each produced a solid quarter ...

2025 Adjusted Operating Margin Forecast: 23.5% to 24% of sales. 2025 Adjusted Tax Rate Forecast: 16% to 17%. Abbott Laboratories (NYSE:ABT) achieved a 9.5% sales growth excluding COVID testing, ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Abbott Laboratories will report earnings pre-market on January 22, with an earnings consensus of $1.04 per share. Abbott continues to execute growth businesses with excellent marketing and ...

Gov. Greg Abbott issued a ban on the use of Chinese-backed artificial intelligence and social media apps on Texas government-issued devices Friday afternoon. The proclamation orders the Texas ...

Gov. Greg Abbott announced he has ordered all flags to be raised to full staff at the Texas Capitol and all state buildings on Monday, Jan. 20, the day President-elect Donald Trump is set to be ...